Skip to main content
. Author manuscript; available in PMC: 2015 Mar 1.
Published in final edited form as: Neuromuscul Disord. 2013 Nov 15;24(3):227–240. doi: 10.1016/j.nmd.2013.11.001

Table 4.

Validation of published missplicing events in dystrophic muscle (t-test)

Gene Event p-value (DM1 vs. N) p-value (DM2 vs. N) p-value (NMD vs. N)*
ANK2 Exclusion exon 43a 0.297000 6.91e-03 nd
ATP2A1 Exclusion exon 22 0.021100 2.68e-11 0.001050
CAPZB Exclusion exon 8a 0.158000 6.05e-03 nd
CLCN1 Inclusion fetal exon 0.011300 4.25e-03 nd
FHOD1 Exclusion exon 11a–12 0.007780 3.41e-10 0.510000
LDB3 Inclusion exon 4 0.064300 5.18e-06 0.526000
LDB3 Inclusion exon 7 0.000291 1.57e-06 0.316000
MBNL1 Inclusion exon 6a/7 0.004010 9.60e-06 0.044800
MBNL2 Inclusion exon 7 0.007990 3.38e-04 0.288000
MEF2A Inclusion exon 5a 0.007620 2.73e-05 0.009280
MEF2C Inclusion exon 5a 0.005230 1.59e-07 0.000883
NRAP Exclusion exon 12 0.953000 3.37e-03 0.017000
PDLIM3 Inclusion exon 5a 0.047500 3.92e-04 0.859000
RYR1 Exclusion exon 70 0.251000 2.39e-02 0.528000
TNNT2 Inclusion exon 5 0.012200 5.99e-02 0.033700
TNNT3 Inclusion fetal exon 0.077700 9.88e-05 0.439000
TTN Inclusion exon 11 0.009280 6.75e-04 0.000719
*

nd, not done.